Lung Cancer Europe Access to Treatment Atlas

Across Europe, access to lung cancer treatments varies significantly depending on where you live. The Lung Cancer Europe Access to Treatment Atlas maps the availability of licensed treatments and biomarker testing across more than 30 European countries, giving advocates, policymakers, and healthcare stakeholders a clear picture of where gaps exist and where action is needed.

Developed with member organisations, clinical partners, and policy networks across Europe, the Atlas is a practical tool for driving stronger advocacy at national and European level.

Explore the Atlas to find out:

Which licensed treatments are available in each country
Where biomarker testing is accessible
How access compares across Europe

Looking for clinical trials? You can search for active lung cancer trials using the EU Clinical Trials map or find out more at Accelerating Clinical Trials.

Lung cancer screening programmes To find out where screening programmes are currently running across Europe, visit the Lung Cancer Policy Network interactive map.

❊ FAQs

The Atlas has been developed with lung cancer advocates in mind, particularly those who are members of Lung Cancer Europe.
The information contained on the Access to Treatment Atlas website may also be of interest to anyone wishing to know more about equity in access to lung cancer treatment, biomarker testing in current European guidelines, and how the pharma industry works.
The information in the ATLAS is a snapshot of the situation at a specific point in time.
Lung Cancer Europe continues to liaise and collaborate with manufacturers, market authorisation holders, member patient organisations, and others to keep the data as up-to-date as possible.
However, due to the constantly changing landscape, there may be delays or inaccuracies in the information. For any suggestions or inaccuracies, please contact atlas@lungcancereurope.eu
The Atlas provides information on treatment options and access levels but is not intended to provide medical advice or to recommend specific treatments.
The decision on the most appropriate treatment for you or your loved one must be made in consultation with your healthcare team.

Can't find a treatment available in your country?

If you know of a treatment that is available in your country but is not currently listed in the Lung Cancer Europe Access to Treatment Atlas, please let us know using the form below.

This form can be submitted anonymously - you do not need to provide your name or contact details. However, if you would like to hear back from us or receive updates about new treatments and additions to the Atlas, you can optionally add your name and email address at the end of the form.

Follow us on LinkedIn

Lung Cancer Europe

c/o Fiduria AG, Brueckfeldstrasse 16

3012 Bern, Switzerland

atlas@lungcancereurope.eu

PRIVACY POLICY